Debt to Equity Ratio Chart

View Debt to Equity Ratio for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 1.772
December 31, 2025 1.659
September 30, 2025 1.871
June 30, 2025 1.731
March 31, 2025 1.782
December 31, 2024 1.564
September 30, 2024 1.842
June 30, 2024 1.902
March 31, 2024 1.917
December 31, 2023 1.880
September 30, 2023 1.805
June 30, 2023 1.711
March 31, 2023 1.838
March 31, 2021 1.359
December 31, 2020 1.353
September 30, 2020 1.318
June 30, 2020 1.313
March 31, 2020 1.298
December 31, 2019 1.474
September 30, 2019 1.534
June 30, 2019 1.590
March 31, 2019 1.635
December 31, 2018 1.487
September 30, 2018 1.535
June 30, 2018 1.548
Date Value
March 31, 2018 1.620
December 31, 2017 1.656
September 30, 2017 1.692
June 30, 2017 1.718
March 31, 2017 1.704
December 31, 2016 1.312
September 30, 2016 1.320
June 30, 2016 1.371
March 31, 2016 1.392
December 31, 2015 1.443
September 30, 2015 1.431
June 30, 2015 1.480
March 31, 2015 1.506
December 31, 2014 1.593
September 30, 2014 1.666
June 30, 2014 1.722
March 31, 2014 1.760
December 31, 2013 1.278
September 30, 2013 1.388
June 30, 2013 1.449
March 31, 2013 1.500
December 31, 2012 1.479
September 30, 2012 1.588
June 30, 2012 1.588
March 31, 2012 1.684

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Amarin Corp. Plc 0.0124
Cellectis SA 1.812
Autolus Therapeutics Plc 3.392
Akari Therapeutics Plc 0.0509
Evaxion AS 0.00